Condition: Frailty · Septic Shock · Sponsor: Centre Hospitalier de Lens
The aim of the study is to demonstrate that "frail" patients, defined as having a CFS score greater than or equal to 5, and "severely" frail patients, defined as having a CFS score between \[6-7\] as defined by Bagshaw et al (14), constitute an independent risk factor (RF) for mortality. In the same way, as an exploratory study, we will try to find out whether clinical frailty constitutes a risk factor for extending the length of hospital stay, the risk of short/medium-term readmission, as has already been demonstrated for patients admitted to intensive care from all causes (15), or for impaired quality of life. The objective is to have a better understanding of the implications and outcomes associated with pre-hospital frailty in young critically ill patients. This analysis will also help to clarify prognoses and contribute to better decision-making on the intensity and proportionality of care, as well as providing better information and helping to manage the expectations of patients and their families in terms of survival prognosis and subsequent quality of life.
This description comes directly from the study's public registry record.
Guillaume DEGOUY, Dr · 03.21.69.12.34 · gdegouy@ch-lens.fr
MELANIE VERLAY · 03.21.69.10.28 · mverlay@ch-lens.fr
Always discuss trial participation with your own doctor first.
| Ch Germon Et Gauthier | Béthune, France | Recruiting |
| CH Boulogne sur Mer | Boulogne-sur-Mer, France | Recruiting |
| CHU de Dijon | Dijon, France | Recruiting |
| CH de Lens | Lens, France | Recruiting |
| CHU Lille | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05928767